Literature DB >> 21815706

Societal values in the allocation of healthcare resources: is it all about the health gain?

Tania Stafinski1, Devidas Menon, Deborah Marshall, Timothy Caulfield.   

Abstract

Over the past decade, public distrust in unavoidable value-laden decisions on the allocation of resources to new health technologies has grown. In response, healthcare organizations have made considerable efforts to improve their acceptability by increasing transparency in decision-making processes. However, the social value judgments (distributive preferences of the public) embedded in them have yet to be defined. While the need to explicate such judgments has become widely recognized, the most appropriate approach to accomplishing this remains unclear. The aims of this review were to identify factors around which distributive preferences of the public have been sought, create a list of social values proposed or used in current resource allocation decision-making processes for new health technologies, and review approaches to eliciting such values from the general public. Social values proposed or used in making resource allocation decisions for new health technologies were identified through three approaches: (i) a comprehensive review of published, peer-reviewed, empirical studies of public preferences for the distribution of healthcare; (ii) an analysis of non-technical factors or social value statements considered by technology funding decision-making processes in Canada and abroad; and (iii) a review of appeals to funding decisions on grounds in part related to social value judgments. A total of 34 empirical studies, 10 technology funding decision-making processes, and 12 appeals to decisions were identified and reviewed. The key factors/patient characteristics addressed through policy statements and around which distributive preferences of the public have been sought included severity of illness, immediate need, age (and its relationship to lifetime health), health gain (amount and final outcome/health state), personal responsibility for illness, caregiving responsibilities, and number of patients who could benefit (rarity). Empirical studies typically examined the importance of these factors in isolation. Therefore, the extent to which preferences around one factor may be modified in the presence of others is still unclear. Research that seeks to clarify interactions among factors by asking the public to weigh several of them at once is needed to ensure the relevance of elicited preferences to real-world technology funding decisions.

Entities:  

Mesh:

Year:  2011        PMID: 21815706     DOI: 10.2165/11588880-000000000-00000

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  74 in total

1.  National Institute for Clinical Excellence and its value judgments.

Authors:  Michael D Rawlins; Anthony J Culyer
Journal:  BMJ       Date:  2004-07-24

2.  Investigating the social value of health changes.

Authors:  Dorte Gyrd-Hansen
Journal:  J Health Econ       Date:  2004-11       Impact factor: 3.883

3.  Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs?

Authors:  Peter de Wolf; Werner B F Brouwer; Frans F H Rutten
Journal:  Int J Health Plann Manage       Date:  2005 Oct-Dec

4.  Health policy and practice management issues in orthopaedic surgery: editorial comment.

Authors:  Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2007-04       Impact factor: 4.176

5.  Public funding of new cancer drugs: Is NICE getting nastier?

Authors:  Anne R Mason; Michael F Drummond
Journal:  Eur J Cancer       Date:  2009-01-08       Impact factor: 9.162

6.  A case study of ex ante, value-based price and reimbursement decision-making: TLV and rimonabant in Sweden.

Authors:  Ulf Persson; Michael Willis; Knut Odegaard
Journal:  Eur J Health Econ       Date:  2009-07-29

7.  Comparative effectiveness research and evidence-based health policy: experience from four countries.

Authors:  Kalipso Chalkidou; Sean Tunis; Ruth Lopert; Lise Rochaix; Peter T Sawicki; Mona Nasser; Bertrand Xerri
Journal:  Milbank Q       Date:  2009-06       Impact factor: 4.911

8.  A study on the ethics of microallocation of scarce resources in health care.

Authors:  P A de Carvalho Fortes; E L C P Zoboli
Journal:  J Med Ethics       Date:  2002-08       Impact factor: 2.903

9.  Reimbursement systems, organisational forms and patient selection: evidence from day surgery in Norway.

Authors:  Pål E Martinussen; Terje P Hagen
Journal:  Health Econ Policy Law       Date:  2009-02-25

10.  A note on a discussion group study of public preferences regarding priorities in the allocation of donor kidneys.

Authors:  Paul Dolan; Rebecca Shaw
Journal:  Health Policy       Date:  2004-04       Impact factor: 2.980

View more
  7 in total

1.  Assessing the impact of deliberative processes on the views of participants: is it 'in one ear and out the other'?

Authors:  Tania Stafinski; Devidas Menon; Yutaka Yasui
Journal:  Health Expect       Date:  2012-02-02       Impact factor: 3.377

Review 2.  Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.

Authors:  J M Stratil; R Baltussen; I Scheel; A Nacken; E A Rehfuess
Journal:  Cost Eff Resour Alloc       Date:  2020-02-11

Review 3.  A systematic review of stated preference studies reporting public preferences for healthcare priority setting.

Authors:  Jennifer A Whitty; Emily Lancsar; Kylie Rixon; Xanthe Golenko; Julie Ratcliffe
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  Value-engineered translation for regenerative medicine: meeting the needs of health systems.

Authors:  Tania Bubela; Christopher McCabe
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

5.  Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study.

Authors:  Sally Wortley; Allison Tong; Emily Lancsar; Glenn Salkeld; Kirsten Howard
Journal:  BMC Med Inform Decis Mak       Date:  2015-07-14       Impact factor: 2.796

6.  Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a Survey.

Authors:  Jeff Richardson; Angelo Iezzi; Gang Chen; Aimee Maxwell
Journal:  Pharmacoecon Open       Date:  2017-03

7.  Social values and health systems in health policy and systems research: a mixed-method systematic review and evidence map.

Authors:  Eleanor Whyle; Jill Olivier
Journal:  Health Policy Plan       Date:  2020-07-01       Impact factor: 3.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.